Sponsor Pipeline

Delcath Systems Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05022901 An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in… Metastatic Ocular Melanoma Active, Not Recruiting
Phase 2
NCT06607458 Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly… Refractory Metastatic Colorectal Cancer Recruiting
NCT06875128 Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly… Metastatic Breast Cancer in the Liver Recruiting
Disease Areas
Melanoma (1) Colorectal Cancer (1) Breast Cancer (1)
Get alerts when Delcath Systems Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free